Cytokinetics Inc (CYTK)
Financial leverage ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 824,316 | 740,614 | 779,899 | 889,815 | 1,014,780 | 1,075,960 | 771,717 | 856,253 | 841,319 | 827,539 | 564,302 | 577,062 | 533,803 | 474,112 | 232,495 | 256,582 | 289,814 | 187,393 | 198,218 | 198,611 |
| Total stockholders’ equity | US$ in thousands | -386,323 | -438,801 | -333,115 | -229,020 | -107,900 | -15,977 | 111,414 | 116,261 | 243,863 | 249,020 | 16,489 | 67,846 | 113,383 | 149,605 | -78,080 | -45,711 | -10,937 | -19,869 | -4,896 | 3,372 |
| Financial leverage ratio | — | — | — | — | — | — | 6.93 | 7.36 | 3.45 | 3.32 | 34.22 | 8.51 | 4.71 | 3.17 | — | — | — | — | — | 58.90 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $824,316K ÷ $-386,323K
= —
The financial leverage ratio for Cytokinetics Inc was not available for Q4 2023, Q3 2023, Q2 2023, and Q1 2023. However, for Q2 2022 and Q1 2022, the financial leverage ratio was 6.93 and 7.36 respectively. This indicates that the company's financial leverage decreased from 7.36 in Q1 2022 to 6.93 in Q2 2022. The decrease in financial leverage suggests that the company may be relying less on debt financing to support its operations and investments during this period. Further analysis of the company's financial statements and overall financial health would be needed to fully assess the impact of the change in the financial leverage ratio.
Peer comparison
Dec 31, 2023